When a GLP-1 medication helps reduce calorie intake, improve insulin sensitivity, and decrease visceral fat, inflammatory burden often improves along with it
While neither inositol nor metformin typically causes hypoglycemia when used alone in non-diabetic individuals, patients should be aware of symptoms such as shakiness, sweating, confusion, or rapid heartbeat
Waist-to-hip ratio, also called WHR, can help identify central obesity and visceral belly fat that BMI alone may miss
The primary physiological actions of GLP-1 include: stimulating glucose-dependent insulin secretion
In CAR T-cell therapy, your T-cells are collected and re-engineered in a laboratory to enhance their cancer-fighting capabilities